{rfName}

Indexed in

License and use

Icono OpenAccess

Altmetrics

Grant support

This work was funded by the "Instituto de Salud Carlos III (ISCIII) " through the project FIS PI20/00569 and co -funded by European Union; "CIBEREHD" is funded by "Instituto de Salud Carlos III" and from the "Commissioner for Universities and Research from the Department of Economy and Knowledge" of the "Generalitat de Catalunya" (AGAUR SGR2017_517) . PO is the recipient of a Rio Hortega grant, this contract is financed by the "Instituto de Salud Carlos III" with European funds from the Recovery, Transformation and Resilience Plan, with file code CM22/00058, by virue of the Resolution of the "Direccion del Instituto de Salud Carlos III, OA., M.P." of December 14, 2022, by which the Rio Hortega contracts are granted, and funded by the European Union -Next Generation EU. CM22/00058 grant from "Instituto de Salud Carlos III (ISCIII) ". AB is the recipient of a Juan Rodes JR20/00024 grant from "Instituto de Salud Carlos III (ISCIII) ".

Share

June 16, 2024
Publications
>
Article

Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked

Publicated to:Jhep Rep. 6 (3): 100996- - 2024-03-01 6(3), DOI: 10.1016/j.jhepr.2023.100996

Authors: Olivas, Pol; Perez-Campuzano, Valeria; Orts, Lara; Montironi, Carla; Magaz, Marta; Ruiz, Pablo; Shalaby, Sarah; Rosich, Pau; Baiges, Anna; Turon, Fanny; Lens, Sabela; Pagan, Juan Carlos Garcia; Hernandez-Gea, Virginia

Affiliations

3.03.01 - Hepatopaties víriques, tòxiques i metabòliques. Institut d'Investigacions Biomèdiques August Pi i Sunyer - Author
Esteatohepatitis i trasplantament de fetge. Institut d'Investigacions Biomèdiques August Pi i Sunyer - Author
European Reference Network Rare Liver Disorders ER, Barcelona Hepat Hemodynam Lab, Barcelona, Spain - Author
Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain - Author
Hosp Clin Barcelona, Liver Unit, Barcelona Hepat Hemodynam Lab, Villarroel 170, Barcelona 08036, Spain - Author
Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hosp Clin Barcelona, Liver Unit,Fdn Recerca Clin Barcelona,Dept Med & C, Barcelona, Spain - Author
See more

Abstract

Background & Aims: Porto -sinusoidal vascular disorder (PSVD) encompasses a group of liver diseases with vascular abnormalities that can cause portal hypertension in the absence of cirrhosis. The new diagnostic criteria allow for coexistence with other liver diseases, however its relationship with chronic hepatitis B (CHB) remains unclear. This study aimed to assess HBV prevalence in a PSVD cohort and evaluate its clinical impact. Methods: This retrospective study was conducted on patients with PSVD at Hospital Clinic Barcelona. HBV serology was evaluated, and patients were categorized into HBV chronic infection, past infection, or no HBV exposure. Clinical characteristics and outcomes were compared. Results: We included 155 patients with PSVD. Prevalence of CHB and past HBV infection in patients with PSVD was higher than in the general population (5.8% vs. 0.5%, p

Keywords

AdultAgedArticleB-virus infectionCataloniChronic hepatitis bClinical featureCohort analysisComorbidityControlled studyDecompensated liver cirrhosisDisease associationDisease courseFemaleFollow upHepatitis b virusHumanHypertensionIdiopathic noncirrhotic portal hypertensionIdiopathic portal hypertensionIncomplete septal cirrhosiIncomplete septal cirrhosisLiverLiver diseaseLiver functionLiver transplantationMajor clinical studyMaleMiddle agedNatural-historyNon-cirrhotic portal hypertensionNonhumanOblit- erative portal venopathyObliterative portal venopathyPorto-sinusoidal vascular diseasePrevalenceRegenerative nodular hyperplasiaRetrospective studySerologyVascular liver diseasesVenous pressure

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Jhep Rep due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position 15/147, thus managing to position itself as a Q1 (Primer Cuartil), in the category Gastroenterology & Hepatology. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 4.6, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Aug 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-08-09, the following number of citations:

  • WoS: 3
  • Scopus: 3
  • Europe PMC: 2

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-09:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 5.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 5 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 22.05.
  • The number of mentions on the social network X (formerly Twitter): 35 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Olivas Alberch, Pol) and Last Author (Hernández Gea, Virginia).

the author responsible for correspondence tasks has been Hernández Gea, Virginia.